CSL Ltd (ASX: CSL) shares ended in the red again at the close of the ASX on Tuesday afternoon.

The shares ended around 1% lower for the day, at $112.04 a piece and they’re now around 4% lower over the past week. It looks like investor sentiment has started softening again.

The shares began rebounding through the first three weeks of June, and are still around 19% higher than an all-time low of just $92.24 earlier in the month.

But CSL shares are still 35% lower year to date and 54% lower than this time last year.

The question now is, if you own the ASX healthcare shares, what should you do with them?

Is it time to buy more in the dip? Hold tight until we know what will happen next? Or sell up before the shares drop to a new low?

Here’s what the experts think.

Are CSL shares a buy, sell or hold?

Analysts are divided on the outlook for CSL shares, although the majority agree there should be some upside ahead.

Market Index data shows most brokers (five out of seven) have a hold rating on CSL shares. However, the $137.04 target price implies a potential 22% upside at the time of writing.

TradingView data also shows that, of 18 analysts, 10 have a hold rating and another eight have a buy or strong buy rating on the stock. 

The average $138.48 target price implies a potential 25% upside at the time of writing. However, some analysts tip the ASX healthcare shares to fall around 8% to $103.49, while others forecast CSL to jump around 76% higher to $197.66, at the time of writing.

UBS recently renewed its buy rating on CSL shares with a 12-month price target of $158. The broker is feeling more positive about the company’s outlook, and believes that this year could mark the low point for CSL’s earnings.

But the team at Peak Asset Management is more bearish and is one of the brokers with a sell rating on the ASX stock. 

The broker said that the biotech giant has materially downgraded its FY26 outlook while announcing about $5 billion of additional non-cash pre-tax impairments across fiscal years 2026 and 2027. It also noted that the CSL Vifor acquisition has underperformed amid government healthcare cost pressures and a higher-interest-rate environment.

Meanwhile, Ord Minnett recently confirmed its hold rating and $117 target price on CSL shares. The broker also said it believes the market is underestimating the challenges its Vifor business is facing and expects earnings to be below consensus estimates.

My view of CSL shares

I don’t think things look too good for CSL shares right now, and short-term growth appears to be limited.

Over the longer term, I think there is still potential. CSL’s growth initiatives seem to be working, and it is operating in a dominant position in a high-growth market.

I think it’s possible that if CSL can turn around its financials, investor confidence will follow. But until then, I’m holding tight. 

The post Down 54%: What should I do with my CSL shares now? appeared first on The Motley Fool Australia.

More reading

• Is this broker right about CSL shares?
• 3 cheap ASX shares that could be hiding in plain sight
• Why A2 Milk, Calix, CSL, and Ioneer shares are charging higher today
• Down 53%, is it time to throw in the towel on CSL shares?
• Should I buy CSL and ResMed shares right now?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Premier Investments Ltd (ASX: PMV) looks like one of Australia’s top shares to consider, given the growth in its business yet lower valuation.

As the chart below shows, the Premier Investments share price is down by 35% since September 2025, despite a bit of recovery in recent weeks.

Premier Investments has three important contributors to its value – Peter Alexander, Smiggle and a large stake of Breville Group Ltd (ASX: BRG.

It’s true that the business faces tougher trading conditions with higher interest rates and stronger inflation, potentially affecting both customers and the company’s cost base.

But, I think the hefty decline has been overdone and seems to assume major, long-term impacts. I think this is an opportunity to invest in one of Australia’s top shares, particularly given Peter Alexander’s prospects.

Strong prospects for Peter Alexander

A few months ago, the pyjamas business reported that in the first half of FY26, it delivered sales growth of 4.9% to $312.3 million. Since the first half of FY20, the business has grown sales at a compound annual growth rate (CAGR) of 13.7%

Peter Alexander continues to invest in its retail channel, delivering good growth within its existing markets of Australia and New Zealand.

It noted that it opened four new stores in the first half of FY26, with one in Victoria and three in NSW.

The company also noted that four existing stores were relocated and/or expanded during the first half of FY26, with investment in upgraded store fitouts aiming to significantly improve the customer shopping experience. Of those four stores, three were in Victoria and one was in New Zealand.

It was noted that more than 15 additional opportunities have been identified for both new and/or larger-format stores in existing markets to better showcase the wider product offering.

I’m particularly excited by the fact that this division has established a presence in the UK, which has a large addressable market. It started with a few stores in London and could continue growing in the years ahead. The growth prospects here make it one of Australia’s top shares to consider, in my view.

It also said it’s exploring international wholesale opportunities with global, quality wholesale partners.

Smiggle is struggling at the moment, but Premier Investment is looking to reset the business and I don’t think the market is considering the fact that conditions could improve.

Finally, Breville has proven itself over the years and continues to expand geographically into markets such as China, South Korea and the Middle East. I’m glad Premier Investments still owns this holding.

Valuation and dividend yield

This looks like one of Australia’s top shares, in my opinion, and its valuation is very compelling.

Based on the FY26 projection on Commsec, the Premier Investments share price is valued at 15x FY26’s estimated earnings with a possible grossed-up dividend yield of 7.5%, including franking credits, at the time of writing. This seems far too cheap to me.

I’m excited about the long-term potential of the business, as well as a few other ASX shares that could help us outperform.

The post A rare buying opportunity in 1 of Australia’s top shares? appeared first on The Motley Fool Australia.

More reading

• 3 top ASX dividend shares to buy with 5% to 7% yields
• Here are the top 10 ASX 200 shares today
• Why did ASX 200 retail shares lead the market last week?

Motley Fool contributor Tristan Harrison has positions in Breville Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

There have been some big returns generated in the mining sector over the next past 12 months.

But what about the next 12 months?

Well, one ASX mining stock that is being tipped by Bell Potter to rise materially is named below.

Let’s see why it could be destined to outperform the market by some distance between now and this time next year.

Which ASX mining stock?

The stock that is getting the team at Bell Potter excited is WA1 Resources Ltd (ASX: WA1).

It is a niobium explorer which owns the Luni Niobium Project in Western Australia.

Bell Potter has been pleased with recent developments and particularly the scaled-up beneficiation testwork results across four composites. It explains:

WA1 Resources has announced scaled-up beneficiation testwork results across four composites representing key Indicated Mineral Resource Estimate (MRE) zones at its 100%-owned Luni Niobium Project (Luni) in Western Australia. The testwork confirms a two-stage flotation regime can produce high-quality niobium concentrates with commercially relevant recoveries across the deposit, using raw site water. The testwork is a significant metallurgical data point and materially de-risks the beneficiation stage of the processing flowsheet.

Bell Potter was also pleased with the concentrate grades that were revealed. It adds:

The headline result is a weighted average concentrate grade of 44% Nb₂O₅ at 54% overall recovery across all four composites (open cycle, bulk float). Critically, Composite A, which incorporates material from the higher-grade portion of the resource area and that also represents the focus area for early years of mining, returned 46% Nb₂O₅ at 67% recovery, a significant uplift on prior results from this area. These results support an upward revision to our recovery assumptions and are directly feeding into the PFS, which remains on track for Q4 CY2026.

Big potential returns

According to the note, the broker has retained its speculative buy rating on the ASX mining stock with an improved price target of $27.20. Based on its current share price of $12.36, this implies potential upside of almost 120%. Bell Potter concludes:

We increase our valuation for WA1 to $27.20/sh (previously $24.40/sh) and maintain Our Speculative Buy recommendation. Our valuation for WA1 is based on a notional development scenario (NDS) for Luni discounted at 10% and risked at 30% to reflect the project’s current stage. We revise our recovery assumptions in our model upward to 54%, which sees our unrisked NPV10% increase from A$1,814m to ~A$2,021m — an ~11% uplift. Key catalysts include: PFS completion and Reserve declaration, further beneficiation optimisation of Composites B– D, downstream refining results, and strategic partner/government engagement.

The post Which ASX mining stock could rocket 100%+ after ‘breakthrough’? appeared first on The Motley Fool Australia.

More reading

• Bell Potter tips 129% upside for this ASX materials stock

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.